Eye Med Distributor's $100M Suit Barred By Deal, Akorn Says

Law360, New York (January 28, 2013, 3:36 PM EST) -- Generic-drug maker Akorn Inc. on Friday asked a New York federal court to dismiss most claims from Fera Pharmaceuticals LLC’s $100 million suit accusing it of trade secrets theft, breach of a supply agreement and unfair competition, arguing the allegations were invalid or barred by the agreement.

According to Akorn’s motion to dismiss, the distributor’s accusations are essentially revenge for Akorn's termination of the supply agreement after Fera failed to make required contractual minimum purchases, and are not based on any rights within the contract....
To view the full article, register now.